Hepatotoxicity Associated with a Short Course of Rosuvastatin

Statins reduce cardiovascular morbidity and mortality with dyslipidemia.Although generally well-tolerated,dose-dependent adverse events develop in 10%-15% patients.In addition,up to 3% patients have mildly elevated serum aminotransferase levels within the 1st year of therapy that are rarely associat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chinese medical journal 2015-06, Vol.128 (12), p.1693-1694
Hauptverfasser:	Hwang, Na, Park, Jin, Cha, Kwang, Kang, Jin
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angina pectoris Aspirin Cardiology Cardiovascular disease Clinical Practice Complications and side effects Dosage and administration Drug dosages Dyslipidemias - drug therapy Enzymes Family medical history Hepatitis Hospitals Humans Internal medicine Laboratories Liver - drug effects Liver - metabolism Liver diseases Male Medical research Medicine Patients Research centers Risk factors Rosuvastatin Rosuvastatin Calcium - adverse effects Rosuvastatin Calcium - therapeutic use Statins 他汀类药物发病率心血管疾病死亡率瑞舒伐他汀短期肝毒性血脂异常
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Statins reduce cardiovascular morbidity and mortality with dyslipidemia.Although generally well-tolerated,dose-dependent adverse events develop in 10%-15% patients.In addition,up to 3% patients have mildly elevated serum aminotransferase levels within the 1st year of therapy that are rarely associated with symptoms.
ISSN:	0366-6999 2542-5641
DOI:	10.4103/0366-6999.158382